Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC et al (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circulation Heart Fail 6(3):606–619

Article  CAS  Google Scholar 

Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. The Lancet 391(10120):572–580

Article  Google Scholar 

Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL et al (2015) Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 372(14):1333–1341

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christ M, Stork S, Dorr M, Heppner HJ, Muller C, Wachter R et al (2016) Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System. Eur J Heart Fail 18(8):1009–1018

Article  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726

Article  CAS  PubMed  Google Scholar 

Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al (2021) Universal definition and classification of heart failure: a Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail

Navab M, Reddy ST, Van Lenten BJ, Fogelman AM (2011) HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 8(4):222–232

Article  CAS  PubMed  Google Scholar 

Mody P, Joshi PH, Khera A, Ayers CR, Rohatgi A (2016) Beyond coronary calcification, family history, and C-reactive protein: cholesterol efflux capacity and cardiovascular risk prediction. J Am Coll Cardiol 67(21):2480–2487

Article  CAS  PubMed  PubMed Central  Google Scholar 

Navab M, Reddy ST, Van Lenten BJ, Anantharamaiah GM, Fogelman AM (2009) The role of dysfunctional HDL in atherosclerosis. J Lipid Res 50 Suppl(Suppl):S145-149

Article  PubMed  Google Scholar 

Zewinger S, Drechsler C, Kleber ME, Dressel A, Riffel J, Triem S et al (2015) Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. Eur Heart J 36(43):3007–3016

CAS  PubMed  Google Scholar 

Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP et al (2016) Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS 30(17):2625–2633

Article  CAS  PubMed  Google Scholar 

Skaggs BJ, Hahn BH, Sahakian L, Grossman J, McMahon M (2010) Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRbeta, chemotaxis and TNFalpha production. Clin Immunol 137(1):147–156

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adams V, Besler C, Fischer T, Riwanto M, Noack F, Hollriegel R et al (2013) Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties. Circ Res 113(12):1345–1355

Article  CAS  PubMed  Google Scholar 

Hunter WG, McGarrah RW 3rd, Kelly JP, Khouri MG, Craig DM, Haynes C et al (2019) High-density lipoprotein particle subfractions in heart failure with preserved or reduced ejection fraction. J Am Coll Cardiol 73(2):177–186

Article  PubMed  Google Scholar 

Pandey A, Patel KV, Segar MW, Shapiro MD, Ballantyne CM, Virani SS et al (2024) Association of high-density lipoprotein parameters and risk of heart failure: a multicohort analysis. JACC Heart Fail 12(7):1242–1253

Article  CAS  PubMed  Google Scholar 

Bettencourt PM (2005) Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart 91(11):1489–1494

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel PJ, Khera AV, Jafri K, Wilensky RL, Rader DJ (2011) The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease. J Am Coll Cardiol 58(20):2068–2075

Article  CAS  PubMed  Google Scholar 

Kelesidis T, Roberts CK, Huynh D, Martinez-Maza O, Currier JS, Reddy ST et al (2014) A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. PLoS ONE 9(11):e111716

Article  PubMed  PubMed Central  Google Scholar 

Roy SS, Nguyen HCX, Angelovich TA, Hearps AC, Huynh D, Jaworowski A, Kelesidis T (2017) Cell-free biochemical fluorometric enzymatic assay for high-throughput measurement of lipid peroxidation in high density lipoprotein. J Visu Exp (128):56325

Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH et al (2024) Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction. N Engl J Med 390(17):1560–1571

Article  CAS  PubMed  Google Scholar 

Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313

Article  PubMed  Google Scholar 

Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM (2004) Antiinflammatory properties of HDL. Circ Res 95(8):764–772

Article  CAS  PubMed  Google Scholar 

Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98(11):1352–1364

Article  CAS  PubMed  Google Scholar 

Navab M, Yu R, Gharavi N, Huang W, Ezra N, Lotfizadeh A et al (2007) High-density lipoprotein: antioxidant and anti-inflammatory properties. Curr Atheroscler Rep 9(3):244–248

Article  CAS  PubMed  Google Scholar 

Jackson AO, Meng J, Tang H, Yin K (2021) High-density lipoprotein-mediated cardioprotection in heart failure. Heart Fail Rev 26(4):767–780

Article  PubMed  Google Scholar 

Jiang H, Zhou Y, Nabavi SM, Sahebkar A, Little PJ, Xu S et al (2022) Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis. Front Cardiovasc Med 9:925923

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM et al (1995) Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96(6):2758–2767

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Wu Z, Riwanto M, Gao S, Levison BS, Gu X et al (2013) Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest 123(9):3815–3828

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaal K, Tarr T, Lorincz H, Borbas V, Seres I, Harangi M et al (2016) High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Lipids Health Dis 15:60

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Zhang Y, Liu H, Bai H, Wang Y, Jiang C et al (2015) Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome. Fertil Steril 103(5):1346–1354

Article  CAS  PubMed  Google Scholar 

Rojas M, Prado Y, Tapia P, Carreño LJ, Cabello-Verrugio C, Simon F (2022) Oxidized high-density lipoprotein induces endothelial fibrosis promoting hyperpermeability, hypotension, and increased mortality. Antioxidants (Basel) 11(12):2469

Pagonas N, Mueller R, Weiland L, Jaensch M, Dammermann W, Seibert FS, Hillmeister P, Buschmann I, Christ M, Ritter O, Westhoff TH, Sasko B, Kelesidis T (2024) Oxidized high-density lipoprotein associates with atrial fibrillation. Heart Rhythm 21(4):362–369

Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B et al (2010) Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16(4):470–474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soumyarani VS, Jayakumari N (2014) Oxidized HDL induces cytotoxic effects: implications for atherogenic mechanism. J Biochem Mol Toxicol 28(11):481–489

Article  CAS